| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |